The cytoskeleton is instrumental in most aspects of cell function, which if controlled and modified, could enable early detection and viable treatment for cancer, Alzheimer's, muscular dystrophy, viral infections, and other devastating conditions. Nanoscale structure is key to the function of the cytoskeleton, which is composed of a set of one-dimensional objects with diameters on the order of 10 nm, including actin, intermediate filaments and microtubules. Functions such as cell division, cell motility, membrane trafficking, intracellular transport of cargo, cell-cell interactions, signal transduction and the establishment and maintenance of cell form are all associated with cytoskeletal processes. Understanding the cellular nanomachinery involved in organizing and moving cytoplasm could offer fundamental insights into cell proliferation, morphogenesis, tissue organization, wound healing, the immune response, stem cell differentiation, development and plasticity of the nervous system and the response of an organism to infectious microbes. Engineering principles and the characteristics of these natural 'devices' will drive the development of new nanoscale tools for cytoskeletal biology. Similarly, elucidating nanoscale aspects of biological phenomena will generate fresh strategies to cure or prevent disease. These strategies will likely rely on either nanotechnology tools or synthetic, biocompatible nanostructures rather than the small molecule drugs and proteins currently in use. We propose to establish a Nanomedicine Development Center to 1. study the assembly and dynamics of cytoskeletal structures, 2. unravel function and regulation of these structures in intracellular traffic, cell division and cell motility, 3. develop and implement nanoscale strategies and tools to overcome the challenges of cytoskeletal research, and 4. build prototype devices and nanomaterials to implementing these new insights for diagnostic and therapeutic purposes. The new Center will be housed at Northwestern's interdisciplinary Institute for Bioengineering and Nanoscience in Advanced Medicine. (IBNAM)

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Concept Development Award (PN1)
Project #
1PN1EY016569-01
Application #
6930714
Study Section
Special Emphasis Panel (ZEY1-VSN (12))
Program Officer
Fisher, Richard S
Project Start
2004-09-30
Project End
2005-07-31
Budget Start
2004-09-30
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$72,795
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
Organized Research Units
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Sato, Kohei; Hendricks, Mark P; Palmer, Liam C et al. (2018) Peptide supramolecular materials for therapeutics. Chem Soc Rev 47:7539-7551